Kaplan-Kraicer, R <br/><br/>
Tamoxifen and RU39411 synergize with mifepristone to produce preimplantation pregnancy loss by increasing embryo transport (rat).  [electronic resource] 

 -  Contraception  Jun 1996 
 - 367-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0010-7824 
<br/><br/><label>Standard No.: </label>10.1016/0010-7824(96)00087-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abortifacient Agents, Steroidal--administration & dosage<br/>Administration, Oral<br/>Animals<br/>Blastocyst--drug effects<br/>Corpus Luteum--cytology<br/>Drug Combinations<br/>Drug Synergism<br/>Embryo Implantation--drug effects<br/>Embryo Loss--chemically induced<br/>Embryonic Development--drug effects<br/>Estradiol--administration & dosage<br/>Estrogen Antagonists--administration & dosage<br/>Female<br/>Mifepristone--administration & dosage<br/>Pregnancy<br/>Rats<br/>Rats, Wistar<br/>Tamoxifen--administration & dosage<br/>Time Factors